Becker Hewes
Net worth: 7 M $ as of 2026-05-30
Net worth: 7 M $ as of 2026-05-30
Becker Hewes is Chief Medical Officer at Blueprint Medicines Corp. In his past career Dr. Hewes held the position of Chief Medical Officer at Repertoire Immune Medicines, Inc. and Executive Director-Translational Clinical Oncology at Novartis Institutes for Biomedical Research, Inc. He received a doctorate from Georgetown University School of Medicine and an undergraduate degree from Vanderbilt University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-04 | 264,629 ( 0.43% ) | 7 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2026-01-04 |
| Companies | Position | End |
|---|---|---|
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 2017-01-31 |
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Georgetown University School of Medicine
Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions